A Clinical Study of Omalizumab in the Treatment of Allergic Asthma(ESSENCE)
Clinical trial NCT06348407 · UNKNOWN
Trial details
- NCT number
- NCT06348407
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-12-01
- Primary completion
- 2024-11-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.